Matches in Nanopublications for { ?s ?p "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1148866.RAYmSgOVrVDIojS9PWMUegt6SbUzkU4bx5bxw3mJK_Otw130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148866.RAYmSgOVrVDIojS9PWMUegt6SbUzkU4bx5bxw3mJK_Otw130_provenance.
- NP1148873.RAAcSe9YzlSPF6ztjUOqgg2VvK_qwbd25oerLzaq6IlTg130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148873.RAAcSe9YzlSPF6ztjUOqgg2VvK_qwbd25oerLzaq6IlTg130_provenance.
- assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1148877.RAqKSRaDmfyY7nACgKogTpuXX-i_T93Gz8YTAkXPC9LKI130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148877.RAqKSRaDmfyY7nACgKogTpuXX-i_T93Gz8YTAkXPC9LKI130_provenance.
- NP914006.RAlAOqsOgv3cf--SjTi5a1sb0gfGAKP8jUx7cwx1ug3CM130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914006.RAlAOqsOgv3cf--SjTi5a1sb0gfGAKP8jUx7cwx1ug3CM130_provenance.
- NP914118.RAs-ZnYsIXeyOwVC1QhuXqMFcrAQBOkt1uWjgiuuKrnrU130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP914118.RAs-ZnYsIXeyOwVC1QhuXqMFcrAQBOkt1uWjgiuuKrnrU130_provenance.
- NP978511.RALHn5bdDPGj5tBO8K8PUXF3EXRxH9jEPLehrDGz-C5gc130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978511.RALHn5bdDPGj5tBO8K8PUXF3EXRxH9jEPLehrDGz-C5gc130_provenance.
- NP1148876.RAJLa97g7oP-VofdomYW5q1FMOWDIm3evB9CXRS0Gx2p4130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1148876.RAJLa97g7oP-VofdomYW5q1FMOWDIm3evB9CXRS0Gx2p4130_provenance.
- NP978599.RAxdtU8q5rgT_Lh29JoH-xfkfstxuIB0fi_8CMVBgYxcc130_assertion description "[ASXL1 but not TET2 mutations adversely impact overall survival of patients suffering systemic mastocytosis with associated clonal hematologic non-mast-cell diseases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP978599.RAxdtU8q5rgT_Lh29JoH-xfkfstxuIB0fi_8CMVBgYxcc130_provenance.